Line 100: | Line 100: | ||
<br> | <br> | ||
<div class="mainbody"> | <div class="mainbody"> | ||
− | First, amplifying Lysep3-D8 gene from a plasmid containing <a href="http://parts.igem.org/Part:BBa_K3034012">BBa_K3034012</a>, we inserted it into an expression vector induced by IPTG(final concentration is 0.5mM) and transformed the recombinant plasmid into <p style="display: inline;font-style: italic">E.coli</p> BL21(DE3). We added the inducer at the logarithmic phase(OD600=0.5) of <p style="display: inline;font-style: italic">E.coli</p> to verify the effect of cleavage of Lysep3-D8 (Fig.1). <br> | + | First, amplifying Lysep3-D8 gene from a plasmid containing <a href="http://parts.igem.org/Part:BBa_K3034012">BBa_K3034012</a>, we inserted it into an expression vector induced by IPTG(final concentration is 0.5mM) and transformed the recombinant plasmid into <p style="display: inline;font-style: italic">E.coli</p> BL21(DE3). We added the inducer at the logarithmic phase(OD600=0.5) of <p style="display: inline;font-style: italic">E.coli</p> to verify the effect of cleavage of Lysep3-D8 (Fig. 1). <br> |
<p>Second, we inserted red fluorescent protein (TagRFP) after the light-sensitive promoter system to characterize the function of the light control system. The control group was under continuous illumination at 470 nm and the experimental group was in absolute dark conditions(all other conditions are exactly the same.). After 24 h, comparing the experimental group with the control group, we found that the experimental group did not show the expected red color visible to the naked eye. In the future, we are going to optimize the light-controlled promoter with methods such as site-specific mutation.</p><br> | <p>Second, we inserted red fluorescent protein (TagRFP) after the light-sensitive promoter system to characterize the function of the light control system. The control group was under continuous illumination at 470 nm and the experimental group was in absolute dark conditions(all other conditions are exactly the same.). After 24 h, comparing the experimental group with the control group, we found that the experimental group did not show the expected red color visible to the naked eye. In the future, we are going to optimize the light-controlled promoter with methods such as site-specific mutation.</p><br> | ||
Line 113: | Line 113: | ||
</div> | </div> | ||
− | <div class="words">Fig.1. Characterization of intracellular cleavage effect of Lysep3-D8 protein(37˚C). The experimental data comes from two sets of biological replicates, repeated three times in each group. </div> | + | <div class="words">Fig. 1. Characterization of intracellular cleavage effect of Lysep3-D8 protein(37˚C). The experimental data comes from two sets of biological replicates, repeated three times in each group. </div> |
<div class="mainbody"> | <div class="mainbody"> | ||
− | Our experimental data shows that when the expression of Lysep3-D8 was induced by the addition of IPTG at a final concentration of 0.5 mM, the difference in Abs600 between the experimental group (IPTG+) and the control group (IPTG-) was larger and larger (Fig.1). That is, the Lysep3-D8 protein obviously inhibited the growth of <p style="display: inline;font-style: italic">E.coli</p> (BL21) (inhibition rate was about 30.7%). | + | Our experimental data shows that when the expression of Lysep3-D8 was induced by the addition of IPTG at a final concentration of 0.5 mM, the difference in Abs600 between the experimental group (IPTG+) and the control group (IPTG-) was larger and larger (Fig. 1). That is, the Lysep3-D8 protein obviously inhibited the growth of <p style="display: inline;font-style: italic">E.coli</p> (BL21) (inhibition rate was about 30.7%). |
</div><br> | </div><br> | ||
<div class="mainbody"> | <div class="mainbody"> |
Revision as of 02:16, 21 October 2019
Overview
Biosafety
Introduction
Parts
Experiments
E.coli
BL21(DE3). We added the inducer at the logarithmic phase(OD600=0.5) ofE.coli
to verify the effect of cleavage of Lysep3-D8 (Fig. 1).Second, we inserted red fluorescent protein (TagRFP) after the light-sensitive promoter system to characterize the function of the light control system. The control group was under continuous illumination at 470 nm and the experimental group was in absolute dark conditions(all other conditions are exactly the same.). After 24 h, comparing the experimental group with the control group, we found that the experimental group did not show the expected red color visible to the naked eye. In the future, we are going to optimize the light-controlled promoter with methods such as site-specific mutation.
Results
E.coli
(BL21) (inhibition rate was about 30.7%).Finally, combined with the second safety mechanism-UV sterilization mechanism, we have minimized the risk of leakage of engineered bacteria and production of harmful bacteria. We provide meaningful advice for hardware in biosafety design.
Horizontal Gene Transfer(HGT)
E.coli
in the future.E.coli
such as the enzyme III subunit δ (holB), methionyl-tRNA synthetase (metG), phosphoglycerate kinase (pgk), etc. can be modified to encode the codon UAG into NSAA L-4, 4'-biphenylalanine (bipA), which has a different size and geometry than any standard amino acid, as well as hydrophobic chemicals that are expected to be compatible with the protein core.References
[2]Wang, S., Gu, J., Lv, M. et al. (2017). The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region. Journal of Microbiology, 55: 403.
[3]Marliere P. (2009). The farther, the safer: a manifesto for securely navigating synthetic species away from the old living world. Systems and Synthetic Biology, 3(1-4):77–84.
[4]Daniel J. Mandell, Marc J. Lajoie, Michael T. Mee, et al. (2015). Biocontainment of genetically modified organisms by synthetic protein design. Nature, 518: 55-60.
Lab Safety
Chasiss
E.coli
DH5a,E.coli
BL21(DE3) ,E.coli
CICIM B0016,E.coli
TOP 10 andE.coli
MC1061, which all belong to RISK GROUP 1, means they are low risk for human being and environment.Part
Expected Protection Mechanism
Disposal
Training
Operation
Laboratory coveralls, gowns or uniforms must be worn at all times for work in the laboratory;
When some volatile toxic reagents are necessary, we will operate in the fume hood; All reagents have designated position and must returned after experiment;
A variety of drugs and reagents must be signed a clean label including the name, concentration, specification, etc.;
Daily decontamination of all work surfaces when work is complete;
Prohibition of food, drink and smoking materials in lab setting;
Pipetting by mouth of any material is forbidden. You must always use the teats, syringes, and pipette-fillers provided;
Contaminated glassware, plastic ware, microscope slides and discarded Petri dishes etc., must be placed in the receptacles indicated by the lecturer in charge;